Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin
نویسندگان
چکیده
منابع مشابه
BRIEF CLINICAL OBSERVATIONS SUPERINFECTION WITH STREPTOCOCCUS PNEUMONlAE DURING THERAPY WITH CIPROFLOXACIN
Ciprofloxacin is a newly released fluoroquinolone antibiotic that has been approved for use in a variety of community-acquired infections, including lower respiratory tract infections. This approval has met with some skepticism, in that the ilz vitro activity of this agent against Streptococcus pneumoniae, the most frequently isolated organism in community-acquired pneumonia, is less than ideal...
متن کاملIncreased Susceptibility for Superinfection with Streptococcus pneumoniae during Influenza Virus Infection Is Not Caused by TLR7-Mediated Lymphopenia
Influenza A virus (IAV) causes respiratory tract infections leading to recurring epidemics with high rates of morbidity and mortality. In the past century IAV induced several world-wide pandemics, the most aggressive occurring in 1918 with a death toll of 20-50 million cases. However, infection with IAV alone is rarely fatal. Instead, death associated with IAV is usually mediated by superinfect...
متن کاملPharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
An in-vitro pharmacokinetic model was used to compare the pharmacodynamics of levofloxacin and ciprofloxacin against four penicillin-susceptible and four penicillin-resistant Streptococcus pneumoniae. Logarithmic-phase cultures were exposed to the peak concentrations of levofloxacin or ciprofloxacin observed in human serum after 500 mg and 750 mg oral doses, human elimination pharmacokinetics w...
متن کاملActivities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
The incidence of ciprofloxacin resistance in Streptococcus pneumoniae is low but steadily increasing, which raises concerns regarding the clinical impact of potential cross-resistance with newer fluoroquinolones. To investigate this problem, we utilized an in vitro pharmacodynamic model and compared the activities of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin to ...
متن کاملFluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy.
Fluoroquinolone-resistant cultures of Streptococcus pneumoniae were isolated from 2 patients who were treated for pneumonia with levofloxacin. Nucleotide sequence analysis of bacterial DNA showed that the isolates contained mutations in both parC (DNA topoisomerase IV) and gyrA (DNA gyrase), which were shown previously to confer fluoroquinolone resistance. With the resistant isolates, the MICs ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The American Journal of Medicine
سال: 1990
ISSN: 0002-9343
DOI: 10.1016/0002-9343(90)90355-h